acquired
Stage
About
Movetis was a biopharmaceutical company that developed and commercialized treatments for gastrointestinal disorders; its lead product was the prokinetic agent prucalopride (marketed as Resolor) for chronic constipation.
Explore Movetis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.